$1.67 0.00 (0.00%) Novogen Shs Sponsored American Deposit Receipt Repr 25 Shs - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 1.67
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 1.67
Open: 1.64
Bid: 1.67
Ask: 1.70
  1. No results found.
  1. Novogen Names John O'Connor as Chairman

    Benzinga | Feb. 5, 2016 | 04:31AM EST
  2. Novogen Engages Contract Research Organisation to Conduct Cantrixil Phase 1 Clinical Trial

    Benzinga | Nov. 24, 2015 | 07:12AM EST
  3. UPDATE: Exercise of Options to Provide Novogen with $690K -6K

    Benzinga | Nov. 16, 2015 | 06:23AM EST
  4. Novogen Patent Covering Cantrixil, Trilexium Accepted in Australia

    Benzinga | Nov. 12, 2015 | 07:22AM EST
  5. Novogen Announces Preclinical Studies Justifies Mode Of Delivery And Dosing Regimen For Anisina

    Benzinga | Nov. 10, 2015 | 16:18PM EST
  6. Novogen Announces 'Cantraxil Plus a Standard-of-Care- Platinum Shown to Prolong Survival in an Animal Model of Recurrent Ovarian Cancer', Then Retracts Announcement

    Benzinga | Oct. 19, 2015 | 03:29AM EST
  7. Novogen Applies for Long-Term Options Listing on ASX

    Benzinga | Sep. 30, 2015 | 05:18AM EST
  8. Novogen Announces Outcome of Comprehensive Science Review

    Benzinga | Aug. 31, 2015 | 06:30AM EST
  9. 6-K from Novogen Shows Details of Immediate Plans for Novogen, Confirms Commitment to Bringing Technology Platforms to The Clinic

    Benzinga | Jul. 30, 2015 | 10:58AM EST
  10. Novogen CEO Outlines Immediate Plans for Co

    Benzinga | Jul. 29, 2015 | 19:00PM EST
  11. UPDATE: Novogen CEO Graham Kelly Resigns

    Benzinga | Jul. 22, 2015 | 05:28AM EST
  12. Novogen Reports Anisina on Track to Enter Clinic in 2016

    Benzinga | Jun. 23, 2015 | 19:36PM EST
  13. Novogen to Present at Bio International Convention Philadelphia 2015

    Benzinga | Jun. 12, 2015 | 05:11AM EST
  14. Novogen Reports Studies Confirm Trxe-009 Crosses The Blood-Brain Barrier

    Benzinga | Jun. 4, 2015 | 06:14AM EST
  15. Novogen Announces Closing of Rights Issue Entitlement Offer, Notice of Shortfall

    Benzinga | Jun. 2, 2015 | 03:36AM EST
Trading Center